SCHEMBL6172195

SCHEMBL6172195

Cc1ccc2c(c1)cc(C(=O)c1ccc(Cl)cc1)n2S(=O)(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 5/20 0.53
▸ HDAC4 P56524 5/20 0.53
▸ HDAC1 Q13547 5/20 0.53
▸ HDAC7 Q8WUI4 5/20 0.53
▸ HDAC2 Q92769 5/20 0.53
▸ HDAC10 Q969S8 5/20 0.53
▸ HDAC11 Q96DB2 5/20 0.53
▸ HDAC8 Q9BY41 5/20 0.53
▸ HDAC6 Q9UBN7 5/20 0.53
▸ HDAC9 Q9UKV0 5/20 0.53
▸ HDAC5 Q9UQL6 5/20 0.53
▸ PPARG P37231 6/20 0.53
▸ PPARA Q07869 5/20 0.53
▸ NOD2 Q9HC29 2/20 0.53
▸ NOD1 Q9Y239 2/20 0.53
▸ PPARD Q03181 4/20 0.49
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HTR1A P08908 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172779 0.87 HDAC3 (0.65) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6170479 0.86 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6422328 0.82 HDAC1 (0.72) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6170056 0.80 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6171376 0.80 HDAC3 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL26082888 0.80 PPARG (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2925789 0.79 PPARG (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18416800 0.79 NOD2 (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17927517 0.78 PPARG (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL741459 0.78 ACLY (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 — — EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 — — US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 — — EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 — — WO disclosed
Send feedback